Cargando…

Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12 complex, in human salivary glands

OBJECTIVES: Recent evidences have revealed that anti-SSA/SSB antibodies, the major autoantibodies in Sjögren's syndrome (SS), are produced in salivary glands. This study aims to clarify overall of autoantibody production at lesion site, including anti-centromere antibody (ACA)-positive SS. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Masaru, Suzuki, Katsuya, Kaneda, Yukari, Yamane, Humitsugu, Ikeura, Kazuhiro, Sato, Hidekazu, Kato, Shin, Tsunoda, Kazuyuki, Arase, Hisashi, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937410/
https://www.ncbi.nlm.nih.gov/pubmed/31611218
http://dx.doi.org/10.1136/annrheumdis-2019-215862
_version_ 1783483870189977600
author Takeshita, Masaru
Suzuki, Katsuya
Kaneda, Yukari
Yamane, Humitsugu
Ikeura, Kazuhiro
Sato, Hidekazu
Kato, Shin
Tsunoda, Kazuyuki
Arase, Hisashi
Takeuchi, Tsutomu
author_facet Takeshita, Masaru
Suzuki, Katsuya
Kaneda, Yukari
Yamane, Humitsugu
Ikeura, Kazuhiro
Sato, Hidekazu
Kato, Shin
Tsunoda, Kazuyuki
Arase, Hisashi
Takeuchi, Tsutomu
author_sort Takeshita, Masaru
collection PubMed
description OBJECTIVES: Recent evidences have revealed that anti-SSA/SSB antibodies, the major autoantibodies in Sjögren's syndrome (SS), are produced in salivary glands. This study aims to clarify overall of autoantibody production at lesion site, including anti-centromere antibody (ACA)-positive SS. METHODS: Antibodies of antibody-secreting cells in human salivary glands were produced as recombinant antibodies. The reactivity of these antibodies and their revertants were investigated by ELISA and newly developed antigen-binding beads assay, which can detect conformational epitopes. The target of uncharacterised antibodies was identified by immunoprecipitation and mass spectrometry. Autoantibody-secreting cells in salivary gland tissue were identified by immunohistochemistry using green fluorescent protein-autoantigen fusion proteins. RESULTS: A total of 256 lesion antibodies were generated, and 69 autoantibodies including 24 ACAs were identified among them. Beads assay could detect more autoantibodies than ELISA, suggesting autoantibodies target to antigens with native conformation. After somatic hypermutations were reverted, autoantibodies drastically decreased antigen reactivity. We showed that MIS12 complex, a novel target of ACA, and CENP-C are major targets of ACA produced in salivary glands by examining cloned antibodies and immunohistochemistry, whereas few anti-CENP-B antibodies were detected. The target profiling of serum ACA from 269 patients with SS, systemic sclerosis (SSc), primary biliary cirrhosis (PBC) and healthy controls revealed that ACA-positive patients have antibodies against various sites of centromere complex regardless of disease. CONCLUSION: We showed direct evidences of antigen-driven maturation of anti-SSA/SSB antibody and ACA in SS lesion. ACA recognises centromere ‘complex’ rather than individual protein, and this feature is common among patients with SS, SSc and PBC.
format Online
Article
Text
id pubmed-6937410
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-69374102020-01-09 Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12 complex, in human salivary glands Takeshita, Masaru Suzuki, Katsuya Kaneda, Yukari Yamane, Humitsugu Ikeura, Kazuhiro Sato, Hidekazu Kato, Shin Tsunoda, Kazuyuki Arase, Hisashi Takeuchi, Tsutomu Ann Rheum Dis Sjögren's Syndrome OBJECTIVES: Recent evidences have revealed that anti-SSA/SSB antibodies, the major autoantibodies in Sjögren's syndrome (SS), are produced in salivary glands. This study aims to clarify overall of autoantibody production at lesion site, including anti-centromere antibody (ACA)-positive SS. METHODS: Antibodies of antibody-secreting cells in human salivary glands were produced as recombinant antibodies. The reactivity of these antibodies and their revertants were investigated by ELISA and newly developed antigen-binding beads assay, which can detect conformational epitopes. The target of uncharacterised antibodies was identified by immunoprecipitation and mass spectrometry. Autoantibody-secreting cells in salivary gland tissue were identified by immunohistochemistry using green fluorescent protein-autoantigen fusion proteins. RESULTS: A total of 256 lesion antibodies were generated, and 69 autoantibodies including 24 ACAs were identified among them. Beads assay could detect more autoantibodies than ELISA, suggesting autoantibodies target to antigens with native conformation. After somatic hypermutations were reverted, autoantibodies drastically decreased antigen reactivity. We showed that MIS12 complex, a novel target of ACA, and CENP-C are major targets of ACA produced in salivary glands by examining cloned antibodies and immunohistochemistry, whereas few anti-CENP-B antibodies were detected. The target profiling of serum ACA from 269 patients with SS, systemic sclerosis (SSc), primary biliary cirrhosis (PBC) and healthy controls revealed that ACA-positive patients have antibodies against various sites of centromere complex regardless of disease. CONCLUSION: We showed direct evidences of antigen-driven maturation of anti-SSA/SSB antibody and ACA in SS lesion. ACA recognises centromere ‘complex’ rather than individual protein, and this feature is common among patients with SS, SSc and PBC. BMJ Publishing Group 2020-01 2019-10-14 /pmc/articles/PMC6937410/ /pubmed/31611218 http://dx.doi.org/10.1136/annrheumdis-2019-215862 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Sjögren's Syndrome
Takeshita, Masaru
Suzuki, Katsuya
Kaneda, Yukari
Yamane, Humitsugu
Ikeura, Kazuhiro
Sato, Hidekazu
Kato, Shin
Tsunoda, Kazuyuki
Arase, Hisashi
Takeuchi, Tsutomu
Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12 complex, in human salivary glands
title Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12 complex, in human salivary glands
title_full Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12 complex, in human salivary glands
title_fullStr Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12 complex, in human salivary glands
title_full_unstemmed Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12 complex, in human salivary glands
title_short Antigen-driven selection of antibodies against SSA, SSB and the centromere ‘complex’, including a novel antigen, MIS12 complex, in human salivary glands
title_sort antigen-driven selection of antibodies against ssa, ssb and the centromere ‘complex’, including a novel antigen, mis12 complex, in human salivary glands
topic Sjögren's Syndrome
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937410/
https://www.ncbi.nlm.nih.gov/pubmed/31611218
http://dx.doi.org/10.1136/annrheumdis-2019-215862
work_keys_str_mv AT takeshitamasaru antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands
AT suzukikatsuya antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands
AT kanedayukari antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands
AT yamanehumitsugu antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands
AT ikeurakazuhiro antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands
AT satohidekazu antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands
AT katoshin antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands
AT tsunodakazuyuki antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands
AT arasehisashi antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands
AT takeuchitsutomu antigendrivenselectionofantibodiesagainstssassbandthecentromerecomplexincludinganovelantigenmis12complexinhumansalivaryglands